Patiromer to Enable Spironolactone Use in the Treatment of Patients with Resistant Hypertension and Chronic Kidney Disease: Rationale and Design of the AMBER Study

Agarwal, R; Rossignol, P; Garza, D; Mayo, MR; Warren, S; Arthur, S; Romero, A; ... Williams, B; + view all Agarwal, R; Rossignol, P; Garza, D; Mayo, MR; Warren, S; Arthur, S; Romero, A; White, WB; Williams, B; - view fewer (2018) Patiromer to Enable Spironolactone Use in the Treatment of Patients with Resistant Hypertension and Chronic Kidney Disease: Rationale and Design of the AMBER Study. American Journal of Nephrology , 48 (3) pp. 172-180. 10.1159/000492622 . Green open access

https://ift.tt/2NahdIE